(Q51772667)

20 July 2018

title

Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. (English)

1 reference

20 July 2018

3

Kamila Czene

1 reference

20 July 2018

21

Laura J Esserman

1 reference

20 July 2018

Katherine A. Hoadley

5

object named as

Katherine A Hoadley

1 reference

20 July 2018

author name string

Linda S Lindström

1

1 reference

20 July 2018

Christina Yau

2

1 reference

20 July 2018

Carlie K Thompson

4

1 reference

20 July 2018

Laura J Van't Veer

6

1 reference

20 July 2018

Ron Balassanian

7

1 reference

20 July 2018

John W Bishop

8

1 reference

20 July 2018

Philip M Carpenter

9

1 reference

20 July 2018

Yunn-Yi Chen

10

1 reference

20 July 2018

Brian Datnow

11

1 reference

20 July 2018

Farnaz Hasteh

12

1 reference

20 July 2018

Gregor Krings

13

1 reference

20 July 2018

Fritz Lin

14

1 reference

20 July 2018

Yanhong Zhang

15

1 reference

20 July 2018

Bo Nordenskjöld

16

1 reference

20 July 2018

Olle Stål

17

1 reference

20 July 2018

Christopher C Benz

18

1 reference

20 July 2018

Tommy Fornander

19

1 reference

20 July 2018

Alexander D Borowsky

20

1 reference

20 July 2018

STO Trialists Group

22

1 reference

20 July 2018

language of work or name

English

0 references

publication date

1 July 2018

1 reference

20 July 2018

Journal of the National Cancer Institute

published in

1 reference

20 July 2018

volume

110

1 reference

20 July 2018

issue

7

1 reference

20 July 2018

page(s)

726-733

1 reference

20 July 2018

Creative Commons Attribution-NonCommercial 4.0 International

copyright license

start time

19 January 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Punctuated copy number evolution and clonal stasis in triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Registers of the Swedish total population and their use in medical research

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

"Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Evolutionary pathways in BRCA1-associated breast tumors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Genome remodelling in a basal-like breast cancer metastasis and xenograft

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Supervised risk predictor of breast cancer based on intrinsic subtypes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

The completeness of the Swedish Cancer Register: a sample survey for year 1998.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Clonal evolution in breast cancer revealed by single nucleus genome sequencing.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Metastasis dormancy in estrogen receptor-positive breast cancer.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Factors predicting late recurrence for estrogen receptor-positive breast cancer

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Biologic markers determine both the risk and the timing of recurrence in breast cancer

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

The pathogenesis of cancer metastasis

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6037086

Metastasis results from preexisting variant cells within a malignant tumor

13 August 2018

1 reference

12 December 2020

Validity of certified causes of death in breast carcinoma patients

1 reference

12 December 2020

The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality

1 reference

12 December 2020

Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study

1 reference

12 December 2020

Circulating tumor cells in patients with breast cancer dormancy

1 reference

12 December 2020

Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJX270

1 reference

20 July 2018

PMCID

6037086

1 reference

20 July 2018

PubMed ID

29361175

1 reference

20 July 2018